Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01FA10	AZM-500	G	Azithromycin - 500mg	500mg	Tablet, film coated	448,843 L.L
L01EB02	APO-ERLOTINIB	G	Erlotinib (HCl) - 100mg	100mg	Tablet	79,672,726 L.L
L02BG04	LETROZOLE BIOGARAN	G	Letrozole - 2.5mg	2.5mg	Tablet, coated	2,402,790 L.L
N01BB58	ARTICAINE MEDIS ADRENALINE	G	Articaine HCl - 40mg/ml, Adrenaline - 0.07mg/ml		Injectable solution	1,881,380 L.L
N03AX14	LEVIPRAM IV	G	Levetiracetam - 500mg/100ml	500mg/100ml	Injectable solution	1,869,733 L.L
N06AA12	DOXEPIN HCl	G	Doxepin (HCl) - 10mg	10mg	Capsule	712,876 L.L
R01AA07	DECOZAL	G	Xylometazoline HCl - 0.05%	0.05%	Metered dose spray	108,851 L.L
R06AE07	FINALLERG	G	Cetirizine (dihydrochloride) - 5mg/5ml	5mg/5ml	Solution	170,668 L.L
A02BA03	FAMODAR 20	G	Famotidine - 20mg	20mg	Tablet, film coated	552,319 L.L
A06AX01	SUPPOSITOIRE GLYCERINE ENFANT	G	Glycerol Stearate USP -		Suppository	179,179 L.L
A10BG03	PIODIAB 15	G	Pioglitazone HCl - 15mg	15mg	Tablet	1,053,317 L.L
B05CX01	10% DEXTROSE INJECTION USP	G	Dextrose,H2O - 10g/100ml	10%	Injectable solution	284,997 L.L
C02CA04	UNIPROST	G	Doxazosin - 4mg	4mg	Tablet	452,875 L.L
C10AA05	TOVAST	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	1,127,484 L.L
D07AC13	ELICA	G	Mometasone furoate micronized - 1mg/g	0.1%	Ointment	399,121 L.L
G04BD08	SOLIFENACINE ARROW	G	Solifenacin succinate - 10mg	10mg	Tablet	952,784 L.L
J01FA10	ZITHROFORTE	G	Azithromycin (dihydrate) - 500mg	500mg	Tablet, film coated	485,127 L.L
L01EB02	MIRATA	G	Erlotinib (HCl) - 100mg	100mg	Tablet, film coated	77,379,009 L.L
L02BG04	LETROZOLE NEAPOLIS	G	Letrozole - 2.5mg	2.5mg	Tablet, film coated	2,060,111 L.L
M01AC02	REUTENOX	G	Tenoxicam - 20mg	20mg	Tablet, coated	576,508 L.L
N01BB58	ORABLOC	G	Articaine HCl - 4%, Epinephrine (tartrate) - 1/100.000		Injectable solution	2,308,721 L.L
N03AX14	LEVIPRAM IV	G	Levetiracetam - 1000mg/100ml	1000mg/100ml	Injectable solution	2,911,659 L.L
N06AA12	DOXEPIN HCl	G	Doxepin (HCl) - 50mg	50mg	Capsule	965,007 L.L
A02BA03	FAMONOR	G	Famotidine - 20mg	20mg	Tablet, film coated	220,390 L.L
A06AX01	SUPPOSITOIRE GLYCERINE ADULTE	G	Glycerol Stearate USP -		Suppository	179,179 L.L
A10BG03	UNIGLIT	G	Pioglitazone HCl - 15mg	15mg	Tablet	685,360 L.L
B01AF01	RIBAVAN	G	Rivaroxaban - 10mg	10mg	Tablet, film coated	959,888 L.L
B05CX01	10% DEXTROSE INJECTION USP	G	Dextrose,H2O - 10g/100ml	10%	Injectable solution	220,643 L.L
C02CA06	TACHYBEN	G	Urapidil - 25mg/5ml	25mg/5ml	Injectable solution	1,439,255 L.L
C09BB04	PRESORYL PLUS	G	Perindopril arginine - 10mg, Amlodipine (besylate) - 5mg		Tablet	770,022 L.L